113 related articles for article (PubMed ID: 11135462)
21. Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease.
Xinarianos G; Scott FM; Liloglou T; Prime W; Turnbull L; Walshaw M; Field JK
Lung Cancer; 2000 Apr; 28(1):37-42. PubMed ID: 10704707
[TBL] [Abstract][Full Text] [Related]
22. Telomerase detection in body fluids.
Hess JL; Highsmith WE
Clin Chem; 2002 Jan; 48(1):18-24. PubMed ID: 11751534
[TBL] [Abstract][Full Text] [Related]
23. Detection of telomerase expression in fine-needle aspirations and fluids.
Cunningham VJ; Markham N; Shroyer AL; Shroyer KR
Diagn Cytopathol; 1998 Jun; 18(6):431-6. PubMed ID: 9626516
[TBL] [Abstract][Full Text] [Related]
24. Weak telomerase activity in malignant cells in metastatic serous effusions: correlation to short survival time.
Zendehrokh N; Franzen L; Dejmek A
Acta Cytol; 2007; 51(3):412-6. PubMed ID: 17536544
[TBL] [Abstract][Full Text] [Related]
25. Lower proliferation rate in metastatic effusion mesothelial cells than in benign effusions.
Rehnberg J; Zendehrokh N; Dejmek A
Anal Quant Cytol Histol; 2007 Aug; 29(4):217-20. PubMed ID: 17879629
[TBL] [Abstract][Full Text] [Related]
26. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
[TBL] [Abstract][Full Text] [Related]
27. Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization.
Johnson TM; Kuffel DG; Dewald GW
Mayo Clin Proc; 1996 Jul; 71(7):643-8. PubMed ID: 8656705
[TBL] [Abstract][Full Text] [Related]
28. p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells.
Mullick SS; Green LK; Ramzy I; Brown RW; Smith D; Gondo MM; Cagle PT
Acta Cytol; 1996; 40(5):855-60. PubMed ID: 8842156
[TBL] [Abstract][Full Text] [Related]
29. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
30. [The negative enrichment by immunomagnetic beads for tumor cells from malignant pleural effusions].
Yang JJ; Xu XX; Min LF; Lin P; Qian GS
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):673-8. PubMed ID: 23158070
[TBL] [Abstract][Full Text] [Related]
31. Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin.
Spangler EA; Rogers KS; Thomas JS; Pustejovsky D; Boyd SL; Shippen DE
J Vet Intern Med; 2000; 14(2):146-50. PubMed ID: 10772485
[TBL] [Abstract][Full Text] [Related]
32. Expression profile of telomerase subunits in human pleural mesothelioma.
Dhaene K; Wauters J; Weyn B; Timmermans JP; van Marck E
J Pathol; 2000 Jan; 190(1):80-5. PubMed ID: 10640996
[TBL] [Abstract][Full Text] [Related]
33. Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study.
Chhieng DC; Ko EC; Yee HT; Shultz JJ; Dorvault CC; Eltoum IA
Diagn Cytopathol; 2001 Dec; 25(6):356-60. PubMed ID: 11747231
[TBL] [Abstract][Full Text] [Related]
34. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
[TBL] [Abstract][Full Text] [Related]
35. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma.
Fiegl M; Kaufmann H; Zojer N; Schuster R; Wiener H; Müllauer L; Roka S; Huber H; Drach J
Hum Pathol; 2000 Apr; 31(4):448-55. PubMed ID: 10821492
[TBL] [Abstract][Full Text] [Related]
36. Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.
Mohanty SK; Dey P
Postgrad Med J; 2003 Oct; 79(936):569-74. PubMed ID: 14612599
[TBL] [Abstract][Full Text] [Related]
37. Telomerase activity in human chorionic villi and placenta determined by TRAP and in situ TRAP assay.
Izutsu T; Kudo T; Sato T; Nishiya I; Ohyashiki K; Mori M; Nakagawara K
Placenta; 1998 Nov; 19(8):613-8. PubMed ID: 9859865
[TBL] [Abstract][Full Text] [Related]
38. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
39. [Application of combined telomerase activity analysis and immunocytochemistry in cytopathologic diagnosis].
Liu Y; Xu ML; Wang J; Wu BQ; Zhong HH; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):181-5. PubMed ID: 22800482
[TBL] [Abstract][Full Text] [Related]
40. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.
Yoshida K; Sugino T; Goodison S; Warren BF; Nolan D; Wadsworth S; Mortensen NJ; Toge T; Tahara E; Tarin D
Br J Cancer; 1997; 75(4):548-53. PubMed ID: 9052409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
